@article{af283601bc9b4ee2a88b46d080c56b43,
title = "Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastoma",
keywords = "Recurrent glioblastoma, End-points, Overall survival, Progression-free survival, Overall survival rates",
author = "Brandes, {Alba A.} and E. Franceschi and Thierry Gorlia and Wolfgang Wick and Jacobs, {A. H.} and Baumert, {B. G.} and {van den Bent}, {Martin J.} and C.M. Weller and Roger Stupp",
year = "2012",
month = apr,
doi = "10.1016/j.ejca.2011.10.027",
language = "English",
volume = "48",
pages = "896--903",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER SCI LTD",
number = "6",
}